Skip to main content

$21.37 0.02 (0.09%)

High

$21.50

Low

$21.07

Trades

54

Turnover

$305,963

Volume

14,319
30 June 2023 at 4:24pm
Register to track AVR and receive email alerts.
Subject
AVR Ann: Repayment of Facility Agreement

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Change of Director's Interest Notice

AVR Ann: Proposed issue of securities - AVR

AVR Ann: Underwriting Agreement - AVRO Listed Options

AVR Ann: Trading Halt

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: DurAVR First in Human Patient Study Follow Up

AVR Ann: DurAVR THV Featured at PCR London Valves

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Change in substantial holding

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve

AVR Ann: Notification of Expiry of Listed Options

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Notice of Extraordinary General Meeting/Proxy Form

AVR Ann: DurAVR selected for PCR London Valves Innovation Session

AVR Ann: Becoming a substantial holder

AVR Ann: Cleansing Notice

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

AVR Ann: Proposed issue of securities - AVR

AVR Ann: Capital Raise

AVR Ann: DurAVR accepted into TCT Innovation session

AVR Ann: Key Partnerships

AVR Ann: Key Animal Study for EFS Submission Completed

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Results of Meeting

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: Chief Medical Officer Appointment

AVR Ann: Extended Manufacturing Agreement

AVR Ann: Appendix 4D and Half Year Financial Report

AVR Ann: Notice of Extraordinary General Meeting/Proxy Form

AVR Ann: Notification of cessation of securities - AVR

AVR Ann: Cleansing Notice

AVR Ann: Application for quotation of securities - AVR

AVR Ann: Notification regarding unquoted securities - AVR

AVR Ann: Proposed issue of securities - AVR

AVR Ann: Capital Raise

AVR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

AVR Ann: Trading Halt

AVR Ann: Patent Grant

Register to track AVR and receive email alerts.

Similar Companies

ANN
MGZ
NAN
NXS
OSX
PNV
SDI
SDI